Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis

M Miravitlles, JL García-Rivero, X Ribera, J Galera… - Respiratory …, 2022 - Springer
Background Persistent airflow limitation and dyspnoea may reduce chronic obstructive
pulmonary disease (COPD) patients exercise capacity and physical activity, undermining …

Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

U Maqsood, TN Ho, K Palmer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a respiratory condition
causing accumulation of mucus in the airways, cough, and breathlessness; the disease is …

Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist …

A Umeda, H Shimada, T Yamane, T Mochizuki… - Frontiers in …, 2023 - frontiersin.org
Background: The Japanese drug use system allowed the once-daily use of inhaled
corticosteroid fluticasone furoate (FF) combined with a long-acting beta-2 agonist vilanterol …

Future concepts in bronchodilation for COPD: dual-versus monotherapy

D Singh, JF Donohue, IH Boucot… - European …, 2021 - Eur Respiratory Soc
Most patients with COPD are recommended to initiate maintenance therapy with a single
long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β2 …

[PDF][PDF] Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française …

M Zysman, BR Baptista, T Soumagne, VM da Silva… - Rev. Des. Mal. Respir, 2021 - splf.fr
La publication des résultats de plusieurs essais randomisés de grande ampleur sur les
traitements pharmacologiques de la BPCO (nouvelles associations fixes, désescalade …

Lung Ultrasound Assessment of Lung Hyperinflation in Patients with Stable COPD: An Effective Diagnostic Tool

Y Chen, J Li, Z Zhu, G Lyu - International Journal of Chronic …, 2024 - Taylor & Francis
Purpose To evaluate the degree of lung hyperinflation (LH) in patients with stable chronic
obstructive pulmonary disease (COPD) by lung ultrasound score (LUS) and assess its value …

[HTML][HTML] Efectos de la rehabilitación pulmonar sobre calidad de vida y tolerancia al esfuerzo

J Betancourt-Peña, JC Ávila-Valencia… - Universidad y …, 2020 - scielo.org.co
Objetivo: Describir los efectos de la RP sobre dos escalas de calidad de vida y su influencia
en la capacidad aeróbica funcional en pacientes con EPOC. Materiales y métodos: Estudio …

The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects

E Derom, GG Brusselle… - Therapeutic Advances in …, 2019 - journals.sagepub.com
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic
obstructive pulmonary disease (COPD). Spiolto® or Stiolto® is a fixed-dose combination …

[PDF][PDF] Lung hyperinflation in chronic obstructive pulmonary disease: clinical and therapeutic relevance

F García-Río - BRN Rev, 2020 - pdfs.semanticscholar.org
Patients with chronic obstructive pulmonary disease (COPD) develop lung hyperinflation
due to limited expiratory flow, loss of elastic recoil of the lungs or the combination of both, a …

Effects of pulmonary rehabilitation on quality of life and exercise tolerance

J Betancourt-Peña, JC Ávila-Valencia… - Universidad y …, 2020 - scielo.org.co
Effects of pulmonary rehabilitation on quality of life and exercise tolerance SciELO - Scientific
Electronic Library Online vol.22 issue2 Flexibility, dynamic balance and core stability for injury …